Year: 2021
Type: article
Abstract: ESRD patients are vulnerable to hypoglycemia due to impaired insulin clearance, glucose metabolism changes, and effects of dialysis. Hypoglycemic events lead to serious and life-threatening complications. Aims for Improvement: To decrease the rate of hypoglycemic events amongst ESRD patients receiving insulin for hyperkalemia treatment.
Source: The Medicine Forum
Authors: Lo, MD, Anna, Mundada, MD, Rachana, Shiffrin, MD, Eric, Wang, MD, Jenny
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W6980928713
